2020: The Industry’s Future Awaits
Applied Clinical Trials, November 2019 Issue (PDF)
Establishing Early Phase Capabilities in Malaysia
How ICH E6 (R2) Offers Wins with Risk-Based Study Execution
The Challenges in Fulfilling the Promise of Precision Oncology
Sponsors Struggle with Trial Disclosure, Patient Privacy Requirements
The ‘Quest’ For an Effective Partner in Pharma And Biotech
China: A New Era of Drug Development and Innovation
Who’s Going to Be Disrupted by Shifts in European Health Strategy?